Vital Pharmaceutical Holdings Limited (1164) - Financial And Strategic Analysis Review --- Aarkstore

Share:    

Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic Analysis Review

Vital Pharmaceutical Holdings Limited (Vital Pharmaceutical) is an investment holding company. The company engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its principal product is Osteoform, a compound calcium amino acid chelate used for the treatment of illnesses caused by osteoporosis and calcium deficiency. The company also focuses on the research and development of biotechnology and provision of logistics and management services. Vital Pharmaceutical markets its products to drug stores, medical institutions, and various supermarkets and shopping malls through a network of dealers and distributors.

This comprehensive SWOT profile of Vital Pharmaceutical Holdings Limited provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vital Pharmaceutical Holdings Limited, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information please visit :

http://www.aarkstore.com/reports/Vital-Pharmaceutical-Holdings-Limited-1164-Financial-and-Strategic-Analysis-Review-51947.html

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise-torfarm S.a. (tfm) - Financial And Strategic Analysis Review Shandong Luoxin Pharmacy Stock Co Ltd 8058 Financial And Strategic Analysis Review --- Aarkstore Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-lifevantage Corporation (lfvn) - Financial And Strategic Analysis Review Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial And Strategic Analysis Review Caplin Point Laboratories Ltd (524742) - Financial And Strategic Analysis Review --- Aarkstore Mediscience Planning Inc. (2182) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Aarkstore Enterprise-lipidviro Tech, Inc. (lpvo) - Financial And Strategic Analysis Review Winteam Pharmaceutical Group Limited (570) - Financial And Strategic Analysis Review --- Aarkstore Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial And Strategic Analysis Review Zhejiang Hangzhou Xinfu Pharma Co Ltd 2019 Financial And Strategic Analysis Review --- Aarkstore Zhejiang Hisoar Pharmaceutical Co Ltd 2099 Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-pt. Pyridam Farma Tbk. (pyfa) - Financial And Strategic Analysis Review